Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [Current developments in use of docetaxel (taxotere) in gynecologic oncology].

× No keyword cloud information.

25 in total

1. A Gompertzian model of human breast cancer growth.

Authors: L Norton
Journal: Cancer Res Date: 1988-12-15 Impact factor: 12.701

2. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18.

Authors: B Fisher; A Brown; E Mamounas; S Wieand; A Robidoux; R G Margolese; A B Cruz; E R Fisher; D L Wickerham; N Wolmark; A DeCillis; J L Hoehn; A W Lees; N V Dimitrov
Journal: J Clin Oncol Date: 1997-07 Impact factor: 44.544

3. Comparative antitumor efficacy of docetaxel and paclitaxel in nude mice bearing human tumor xenografts that overexpress the multidrug resistance protein (MRP)

Authors: U Vanhoefer; S Cao; A Harstrick; S Seeber; Y M Rustum
Journal: Ann Oncol Date: 1997-12 Impact factor: 32.976

4. Relationships between the structure of taxol analogues and their antimitotic activity.

Authors: F Guéritte-Voegelein; D Guénard; F Lavelle; M T Le Goff; L Mangatal; P Potier
Journal: J Med Chem Date: 1991-03 Impact factor: 7.446

5. High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial.

Authors: W R Bezwoda; L Seymour; R D Dansey
Journal: J Clin Oncol Date: 1995-10 Impact factor: 44.544

10. High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer.

Authors: W P Peters; M Ross; J J Vredenburgh; B Meisenberg; L B Marks; E Winer; J Kurtzberg; R C Bast; R Jones; E Shpall
Journal: J Clin Oncol Date: 1993-06 Impact factor: 44.544

[Current developments in use of docetaxel (taxotere) in gynecologic oncology].

1. A Gompertzian model of human breast cancer growth.

2. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18.

3. Comparative antitumor efficacy of docetaxel and paclitaxel in nude mice bearing human tumor xenografts that overexpress the multidrug resistance protein (MRP)

4. Relationships between the structure of taxol analogues and their antimitotic activity.

5. High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial.

6. A prospective randomized comparison of epirubicin and doxorubicin in patients with advanced breast cancer.

7. Cancer statistics, 1996.

8. Phase II study of doxorubicin versus epirubicin in advanced breast cancer.

9. Phase II randomized study of paclitaxel versus mitomycin in advanced breast cancer.

10. High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer.